RE: iqai rns12 Jun 2021 12:12
IQ-AI climbed 14 per cent to just under 9p after its synthetic T1+C (Gad-Free) software application was awarded a patent by the US Patent and Trademark Office.
The technology eliminates the need to intravenously inject a contrast agent during medical imaging procedures, the company said, adding that the patent underscores the potential of artificial intelligence, its ability to streamline workflows, enhance diagnostic quality, and improve patient safety.
Daily mail ...
I expect this to 5 bag in the next year